Self-reported History of Heart Attack among Patients with Type 1 versus Type 2 Myocardial Infarction
Abstract Body (Do not enter title and authors here): Background: The term “heart attack” is synonymous with myocardial infarction (MI). Epidemiologic studies that track MI incidence often rely on patient self-reported history of heart attack. We sought to compare patient self-reported history of heart attack shortly after a diagnosis of type 1 MI (T1MI) and type 2 MI (T2MI). Methods: In this single-center prospective cohort study, 150 consecutively eligible patients meeting strict Universal Definition of MI criteria for T1MI (n=75) and T2MI (n=75) were enrolled. Participants completed baseline (during their index MI hospitalization) and 1-month (4-6 weeks post-discharge) FRAIL scale questionnaires, including the question: “Did your doctor ever tell you that you have had a heart attack?” Multivariable logistic regression analysis evaluated the association between patient characteristics (age, sex, prior MI before the index MI, and presenting MI subtype) and self-reported history of heart attack. Results: 149 baseline questionnaires and 92 1-month questionnaires were available at the time of this analysis, in which 108 participants (72%) self-reported a diagnosis of heart attack at either baseline or 1 month. Among all participants (n=149), individuals who were White (79.6% vs 61.0%, p=0.006) and who had a prior MI before their index MI (24.1% vs 7.3%, p=0.04) more commonly self-reported a heart attack. Patients with T2MI less commonly reported having had a heart attack shortly after their MI as compared to T1MI (54.7% vs 90.5%, p<0.001). Among individuals with T2MI (n=75), individuals with a prior MI before their index MI (31.7% vs 8.8%, p=0.03), higher peak high-sensitivity troponin concentrations (363 ng/L [IQR, 132, 673] vs 139 ng/L [73, 363], p=0.02), and those who underwent invasive coronary angiography (63.4% vs 29.4%, p=0.007) more often self-reported a heart attack. After adjusting for age, gender, race, and prior MI, T2MI patients were significantly less likely to report a history of heart attack than T1MI patients (odds ratio: 0.13 [95% CI, 0.04, 0.32]). Conclusion: Individuals who experienced a T2MI were almost 8 times less likely to report having had a heart attack shortly after their MI event as compared to those with T1MI. These results suggest that epidemiology studies that rely on self-reported history of heart attack may not accurately capture all MI subtypes. Further research is needed to better understand how clinicians communicate a diagnosis of T2MI and patients’ understanding of the diagnosis.
Luterstein, Elaine
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Kitzman, Dalane
( Wake Forest University School of Medicine
, Winston-Salem
, North Carolina
, United States
)
Spertus, John
( University of Missouri-Kansas City’s Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute
, Kansas City
, Missouri
, United States
)
Huffman, Jeff
( Massachusetts General Hospital
, Boston
, Massachusetts
, United States
)
Natarajan, Pradeep
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Januzzi, James
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Mccarthy, Cian
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Tong, Nhi
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Murphy, Sean
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Raghavan, Avanthi
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Paquette, Charlotte
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Lin, Claire
( Harvard Medical School
, Boston
, Massachusetts
, United States
)
Liu, Yuxi
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Wasfy, Jason
( Massachusetts General Brigham
, Boston
, Massachusetts
, United States
)
Doros, Gheorghe
( Boston University School of Public Health
, Boston
, Massachusetts
, United States
)
Author Disclosures:
Elaine Luterstein:DO NOT have relevant financial relationships
| Dalane Kitzman:No Answer
| John Spertus:DO have relevant financial relationships
;
Consultant:BioHaven, Janssen, Bristol Meyers Squibb, Terumo, Cytokinetics, BridgeBio, VentricHealth, and Imbria:Active (exists now)
; Executive Role:Blue Cross Blue Shield of Kansas City:Active (exists now)
; Royalties/Patent Beneficiary:SAQ, KCCQ, PAQ:Active (exists now)
| Jeff Huffman:No Answer
| Pradeep Natarajan:DO have relevant financial relationships
;
Researcher:Amgen, Genentech / Roche:Active (exists now)
; Other (please indicate in the box next to the company name):Vertex Pharmaceuticals (spousal employment):Active (exists now)
; Ownership Interest:Bolt, Candela, Mercury, MyOme, Parameter Health, Preciseli, TenSixteen Bio:Active (exists now)
; Consultant:Allelica, CRISPR Therapeutics, Genentech/Roche, HeartFlow, Magnet Biomedicine:Past (completed)
; Consultant:AstraZeneca, Blackstone Life Sciences, Bristol Myers Squibb, Eli Lilly & Co, Esperion Therapeutics, Foresite Capital, Foresite Labs, GV, Merck, Novartis, Novo Nordisk, TenSixteen Bio, Tourmaline Bio:Active (exists now)
; Researcher:Allelica, Novartis:Past (completed)
| James Januzzi:DO have relevant financial relationships
;
Individual Stocks/Stock Options:Imbria:Active (exists now)
; Researcher:Celecor:Active (exists now)
; Consultant:Roche:Active (exists now)
; Consultant:Jana Care:Active (exists now)
; Consultant:Beckman:Active (exists now)
; Consultant:Abbott:Active (exists now)
; Researcher:Novartis:Active (exists now)
; Researcher:BMS:Active (exists now)
; Researcher:AstraZeneca:Active (exists now)
; Researcher:Applied Therapeutics:Active (exists now)
; Researcher:Abbott:Active (exists now)
; Individual Stocks/Stock Options:Prevencio:Active (exists now)
; Individual Stocks/Stock Options:Fibrosys:Active (exists now)
; Individual Stocks/Stock Options:Jana Care:Active (exists now)
| Cian McCarthy:DO have relevant financial relationships
;
Consultant:HeartFlow:Active (exists now)
; Consultant:NewAmsterdam Pharma:Active (exists now)
; Consultant:Abbott Laboratories:Past (completed)
; Consultant:Roche Diagnostics:Active (exists now)
| Nhi Tong:No Answer
| Sean Murphy:DO NOT have relevant financial relationships
| Avanthi Raghavan:DO NOT have relevant financial relationships
| Charlotte Paquette:DO NOT have relevant financial relationships
| Claire Lin:No Answer
| Yuxi Liu:DO NOT have relevant financial relationships
| Jason Wasfy:DO NOT have relevant financial relationships
| Gheorghe Doros:DO NOT have relevant financial relationships